MedTrace Logo

Yinhu Qingwen Granule in the Treatment of Viral Pneumonia

NCT04955223 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-11-15

No results posted yet for this study

Summary

This is a non-randomized single arm clinical study to observe the effect of Yinhu Qingwen Granule in the relief of fever and improvement of related-symptoms of patients with viral pneumonia.

Conditions

  • Viral Pneumonia

Interventions

DRUG

Yinhu Qingwen Granules

For mild and common patients, take 1 bag 2 times a day. For severe patients, take 1 bag 3 times a day.

Sponsors & Collaborators

  • Zhong Wang

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-31
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04955223 on ClinicalTrials.gov